AI/ML Innovations Retains North Equities Corp
TORONTO, ON / ACCESSWIRE / February 25, 2021 / AI/ML Innovations Inc. (CSE:AIML), a company…
TORONTO, ON / ACCESSWIRE / February 25, 2021 / AI/ML Innovations Inc. (CSE:AIML), a company…
DESTIN, FL / ACCESSWIRE / February 25, 2021 / Four action-packed bouts have been added…
VANCOUVER, BC / ACCESSWIRE / February 25, 2021 / YDX Innovation Corp (TSXV:YDX)(OTC PINK:YDRMF)(FSE:APY1) (“YDX”…
Launch Confirms Empower Stated Strategy To Execute National Clinic Expansion Following Canadian Clinics Acquisition And…
SHERIDAN, WY / ACCESSWIRE / February 25, 2021 /Â Recently Oduwa Coin has announces the launching…
LONDON, UK / ACCESSWIRE / February 2021 / Gamesys Group plc, (OTC PINK:JKPTF) a leading…
LONDON, UK / ACCESSWIRE / February 25, 2021 / Gamesys Group plc, (OTC PINK:JKPTF) a…
VANCOUVER, BC / ACCESSWIRE / February 25, 2021 / LINK GLOBAL TECHNOLOGIES INC. (CSE:LNK)(FRA:LGT)(OTC PINK:LGLOF)…
VANCOUVER, BC / ACCESSWIRE / February 25, 2021 / Pampa Metals Corp. (“Pampa Metals” or…
Leading advisory business steps up to support UK corporates LONDON – Exton Advisors, a leading…
UKCloud’s focus and commitment to its ‘Powered By’ programme demonstrates how Technology Providers are key…
Cradlepoint and Panasonic solution in 66 fleet vehicles enables Norfolk Fire & Rescue to send…
Finsit enables accountants to leverage technology to give real-time, data-rich advice 25 February 2021: Kingston,…
Debrichem® offers a very effective, alternative approach to chronic wound care, initiating healing in more…
Positive Phase 2 results with pMDI ensifentrine in COPD Enrollment ongoing in ENHANCE Phase 3…
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that a collaboration agreement has been signed…
JANUARY – DECEMBER 2020 Net sales amounted to MSEK 0.3 (0.0) Operating expenses amounted to…
February 25, 2021Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company…
Excellent progress on clinical programs Unprecedented partnering deal signed with Pfizer for Lyme disease vaccine…
FIREFISH Part 1 data show treatment with Evrysdi at 12 months helped 90% of these…